Mori K, Pradere B, Moschini M, Mostafaei H, et al. First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysis. Eur J Cancer 2021;151:35-48.
PMID: 33962359